SCHEMBL24344399

SCHEMBL24344399

CN(C)Cc1ccn2c(=O)c(-c3ccc4c(c3)OCO4)cnc2c1C1CCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM2 Q14416 3/20 0.38
▸ RET P07949 4/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38
▸ KDR P35968 2/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ PRNP P04156 1/20 0.36
▸ FYN P06241 3/20 0.36
▸ MCHR1 Q99705 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17808838 0.84 FYN (0.45) GRM2RETCYP1A2CYP3A4CYP2D6
SCHEMBL24345099 0.82 RET (0.40) GRM2RETCYP1A2CYP3A4CYP2D6
SCHEMBL24344175 0.77 CCNE1 (0.35) RETCLK4KDRFYNBTK
SCHEMBL24344137 0.76 CHEK1 (0.34) RETCLK4KDRFYNPDE4B
SCHEMBL24345095 0.76 CHEK1 (0.34) RETCLK4KDRFYNPDE4B
SCHEMBL24345092 0.70 ALDH1A1 (0.41) TSHRHSD17B10MAPTPDE4B
SCHEMBL17808773 0.70 GAPDH (0.47) RETCYP1A2CYP3A4CYP2D6TSHR
SCHEMBL24344150 0.70 ALDH1A1 (0.41) —
SCHEMBL17802288 0.65 CDK9 (0.47) RETCLK4KDRFYNBTK
SCHEMBL6048484 0.63 GABRA1 (0.49) GRM2CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227292-B1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS ALTERITY THERAPEUTICS LTD (AU) 2022-03-09 — — EP disclosed
Send feedback